Financial ties between DSM-IV panel members and the pharmaceutical industry

L Cosgrove, S Krimsky, M Vijayaraghavan… - Psychotherapy and …, 2006 - karger.com
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

[PDF][PDF] Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

LCSKM Vijayaraghavana, L Schneidera - Psychother Psychosom, 2006 - academia.edu
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

[PDF][PDF] Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

LCSKM Vijayaraghavana, L Schneidera - Psychother Psychosom, 2006 - ahrp.org
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

[PDF][PDF] Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

LCSKM Vijayaraghavana… - Psychother …, 2006 - behaviorismandmentalhealth.com
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

Financial ties between DSM-IV panel members and the pharmaceutical industry

L Cosgrove, S Krimsky… - Psychotherapy and …, 2006 - pubmed.ncbi.nlm.nih.gov
Background Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

L Cosgrove, S Krimsky, M Vijayaraghavan… - Psychotherapy and …, 2006 - JSTOR
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

[PDF][PDF] Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

LCSKM Vijayaraghavana, L Schneidera - Psychother Psychosom, 2006 - hviteorn.no
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …

Financial Ties Between DSM-IV Panel Members and the Pharmaceutical Industry

L Cosgrove, S Krimsky, M Vijayaraghavan, L Schneider - pdfs.semanticscholar.org
Financial Ties Between DSM- IV Panel Members and the Pharmaceutical Industry Page 1
Financial Ties Between DSMIV Panel Members and the Pharmaceutical Industry Lisa Cosgrove …

[引用][C] Financial ties between DSM-IV panel members and the pharmaceutical industry

L COSGROVE, S KRIMSKY… - Psychotherapy and …, 2006 - pascal-francis.inist.fr
Financial ties between DSM-IV panel members and the pharmaceutical industry CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

[PDF][PDF] Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

LCSKM Vijayaraghavana, L Schneidera - Psychother Psychosom, 2006 - sites.tufts.edu
Background: Increasing attention has been given to the transparency of potential conflicts of
interest in clinical medicine and biomedical sciences, particularly in journal publishing and …